首页> 外文OA文献 >Everolimus in Combination with Pemetrexed in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with Chemotherapy A Phase I Study Using a Novel, Adaptive Bayesian Dose-Escalation Model

【2h】

Everolimus in Combination with Pemetrexed in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with Chemotherapy A Phase I Study Using a Novel, Adaptive Bayesian Dose-Escalation Model

机译：先前已接受化疗的晚期非小细胞肺癌晚期患者联合依维莫司和培美曲塞进行的一项I期研究，采用新型自适应贝叶斯剂量递增模型

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

status: published

机译：状态：已发布

著录项

作者
Vansteenkiste, Johan; Solomon, Benjamin; Boyer, Michael; Wolf, Juergen; Miller, Neil; Di Scala, Lilla; Pylvaenaeinen, Ilona; Petrovic, Katarina; Dimitrijevic, Sasa; Anrys, Beatrijs; Laack, Eckart;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Everolimus in combination with pemetrexed in patients with advanced non-small cell lung cancer previously treated with chemotherapy: a phase I study using a novel, adaptive Bayesian dose-escalation model. [J] . Vansteenkiste J, Solomon B, Boyer M, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2011,第12期

机译：依维莫司联合培美曲塞治疗已接受化疗的晚期非小细胞肺癌患者：I期研究采用新型适应性贝叶斯剂量递增模型。
2. A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non-small cell lung cancer [J] . Soria Jean-Charles, Adjei Alex A., Bahleda Rastilav, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2017,第期

机译：IB剂量 - 升级对PictIlaxel和Carboplatin（有或没有Bevacizumab）或Pemetroxed和顺铂（有或没有或没有或没有Bevacizumab）的患者的安全和药代动力学的升级研究
3. A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer. [J] . L Q M Chow, N Blais, D J Jonker, Cancer chemotherapy and pharmacology. . 2012,第3期

机译：舒尼替尼联合培美曲塞在晚期实体恶性肿瘤患者中的I期剂量递增和药代动力学研究，并扩大了非小细胞肺癌的队列。
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
6. A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies with an expanded cohort in non-small cell lung cancer [O] . L. Q. M. Chow, N. Blais, D. J. Jonker, -1

机译：舒尼替尼联合培美曲塞治疗晚期实体恶性肿瘤且非小细胞肺癌队列扩大的I期剂量递增和药代动力学研究
7. Everolimus in Combination with Pemetrexed in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with Chemotherapy: A Phase I Study Using a Novel, Adaptive Bayesian Dose-Escalation Model [O] . Vansteenkiste Johan, Solomon Benjamin, Boyer Michael, 2011

机译：依维莫司联合培美曲塞治疗晚期非小细胞肺癌先前接受化疗的患者：使用新型适应性贝叶斯剂量递增模型的I期研究

Everolimus in Combination with Pemetrexed in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with Chemotherapy A Phase I Study Using a Novel, Adaptive Bayesian Dose-Escalation Model

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅